Answers are grounded in this paper and cite their sources.
Polycystic ovary syndrome (PCOS), is a prevalent cause of infertility worldwide. This study aimed to assess endocrinological and biochemical alterations and analyze oxidative stress in women with PCOS. A cohort of PCOS patients was examined for various clinical manifestations. We investigated the levels of several key parameters, including antioxidants, hormones (Luteinizing Hormone, Follicle Stimulating Hormone, Estradiol, and Testosterone), and hematological parameters. The study revealed that PCOS patients showed significantly higher levels of testosterone, while LH levels were lower in the non-PCOS group. FSH concentration was reduced in the PCOS group. Antioxidant levels demonstrated statistically significant differences between PCOS and non-PCOS females. A majority of PCOS patients experienced symptoms such as hair loss, hirsutism and menstrual irregularities. Menarche occurred at an early age, with PCOS females experiencing it at 13 years. A substantial portion of the population (84%) reported experiencing pain during periods, yet only a small fraction (14%) were using medication for pain relief. Ultrasonography revealed findings of a thickened endometrium and multiple cysts ranging from 5 to 7 mm. The findings reveal substantial hormonal imbalances, elevated testosterone levels, and significant differences in luteinizing hormone and follicle-stimulating hormone dynamics, underscoring the endocrinological complexity of PCOS. The high prevalence of distressing clinical manifestations and the underutilization of pain relief medication among PCOS patients emphasize the need for improved symptom management and healthcare interventions.
No takes yet. Share an insight, caveat, or question.
Ikram et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: